뉴스
- Seoul stocks open sharply lower on lingering concerns over AI, U.S. infla... Seoul stocks have continued their losing streak for the past six consecutive...
- FromBio Hits Limit-Up as Trading Resumes; Curacle Surges on Follow-On Licensing Hopes [K-Bio Puls... On Aug. 10, South Korean pharmaceutical and biotech stocks broadly advanced as the KOSDAQ rebounded. FromBio soared to the daily upper limit as trading resumed following a 5-for-1 reverse stock split...
- [K-Bio Pulse]Black Friday Hits Korean Biotech pharmaceutical and biotech sector suffered broad-based losses on July 3 in what resembled a "Black Friday" for Stocks that had recently announced major positive developmen...